|
ARID2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.013400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.293900E-02 |
| Normal-vs-Stage2 |
2.726800E-01 |
| Normal-vs-Stage3 |
4.730200E-01 |
| Normal-vs-Stage4 |
7.807600E-01 |
| Stage1-vs-Stage2 |
9.425800E-01 |
| Stage1-vs-Stage3 |
6.182800E-01 |
| Stage1-vs-Stage4 |
7.142000E-01 |
| Stage2-vs-Stage3 |
7.314400E-01 |
| Stage2-vs-Stage4 |
8.201800E-01 |
| Stage3-vs-Stage4 |
9.604400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.080210E-01 |
| Normal-vs-AfricanAmerican |
5.597600E-01 |
| Normal-vs-Asian |
1.179840E-01 |
| Caucasian-vs-AfricanAmerican |
5.068800E-01 |
| Caucasian-vs-Asian |
6.926400E-01 |
| AfricanAmerican-vs-Asian |
5.102000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.716400E-02 |
| Normal-vs-Female |
4.237200E-01 |
| Male-vs-Female |
1.590480E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.923780E-01 |
| Normal-vs-Extreme_Weight |
1.268180E-02 |
| Normal-vs-Obese |
9.726000E-01 |
| Normal-vs-Extreme_Obese |
3.775700E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.226800E-01 |
| Normal_Weight-vs-Obese |
2.626400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.364600E-01 |
| Extreme_Weight-vs-Obese |
3.355800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.100600E-01 |
| Obese-vs-Extreme_Obese |
7.542200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.522400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.692400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.656000E-03 |
| Normal-vs-Age(81-100Yrs) |
1.081760E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.785000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.008200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.892300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.551000E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.044200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.357000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.149400E-01 |
| Normal-VS-Type2 PRCC |
2.242000E-03 |
| Normal-VS-KIRP CIMP |
4.942000E-01 |
| Normal-VS-Unclassified PRCC |
6.507400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.608180E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.405200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.468400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.614000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.780500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.754600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.460300E-03 |
| Normal-vs-N1 |
3.713600E-01 |
| Normal-vs-N2 |
6.527800E-01 |
| N0-vs-N1 |
1.991650E-02 |
| N0-vs-N2 |
3.861000E-01 |
| N1-vs-N2 |
5.726800E-01 |
|
|
